LNK International, Inc. - June 14, 2013

Not all periodic reports contained a narrative summary and analysis of the information in the report, an analysis of the postmarketing 15-day alert reports submitted during the reporting interval, and an FDA Form 3500A for each adverse drug experience not reported as a postmarketing 15-day Alert report.